Halozyme Therapeutics Inc (HALO)
38.97
+0.26
(+0.67%)
USD |
NASDAQ |
Apr 23, 16:00
38.96
-0.01
(-0.03%)
After-Hours: 20:00
Halozyme Therapeutics Shareholders Equity (Quarterly): 83.81M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 83.81M |
September 30, 2023 | 249.18M |
June 30, 2023 | 151.03M |
March 31, 2023 | 65.85M |
December 31, 2022 | 169.80M |
September 30, 2022 | 96.99M |
June 30, 2022 | 293.17M |
March 31, 2022 | 260.26M |
December 31, 2021 | 196.95M |
September 30, 2021 | 281.67M |
June 30, 2021 | 119.75M |
March 31, 2021 | 67.60M |
December 31, 2020 | 151.05M |
September 30, 2020 | 98.99M |
June 30, 2020 | 105.58M |
March 31, 2020 | 58.04M |
December 31, 2019 | 91.76M |
September 30, 2019 | 245.35M |
June 30, 2019 | 260.05M |
March 31, 2019 | 260.05M |
December 31, 2018 | 248.89M |
September 30, 2018 | 239.74M |
June 30, 2018 | 254.92M |
March 31, 2018 | 265.06M |
December 31, 2017 | 208.37M |
Date | Value |
---|---|
September 30, 2017 | 72.39M |
June 30, 2017 | 58.16M |
March 31, 2017 | -58.50M |
December 31, 2016 | -32.48M |
September 30, 2016 | -11.99M |
June 30, 2016 | 9.92M |
March 31, 2016 | 29.47M |
December 31, 2015 | 43.00M |
September 30, 2015 | 31.80M |
June 30, 2015 | 50.23M |
March 31, 2015 | 37.54M |
December 31, 2014 | 41.35M |
September 30, 2014 | 39.94M |
June 30, 2014 | 55.30M |
March 31, 2014 | 66.75M |
December 31, 2013 | -19.99M |
September 30, 2013 | -3.486M |
June 30, 2013 | 11.14M |
March 31, 2013 | 31.68M |
December 31, 2012 | 48.85M |
September 30, 2012 | 51.19M |
June 30, 2012 | 69.23M |
March 31, 2012 | 81.06M |
December 31, 2011 | 10.90M |
September 30, 2011 | 27.06M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
58.04M
Minimum
Mar 2020
293.17M
Maximum
Jun 2022
160.36M
Average
151.03M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
Johnson & Johnson | 68.77B |
Globus Medical Inc | 3.998B |
Denali Therapeutics Inc | 1.031B |
AIM ImmunoTech Inc | 10.23M |
Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.733B |
Total Liabilities (Quarterly) | 1.649B |
Debt to Equity Ratio | 17.89 |
Current Ratio | 6.635 |
Net Debt Paydown Yield | 0.02% |